These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 4887336

  • 1. [On the biochemistry of thrombins].
    Walsmann P, Markwardt F.
    Pharmazie; 1968 Nov; 23(11):597-608. PubMed ID: 4887336
    [No Abstract] [Full Text] [Related]

  • 2. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ, Sanderson PE.
    Coron Artery Dis; 1998 Nov; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract] [Full Text] [Related]

  • 3. Antithrombin as proteinase inhibitor.
    Seegers WH.
    Ann N Y Acad Sci; 1968 Jun 28; 146(2):593-600. PubMed ID: 5254273
    [No Abstract] [Full Text] [Related]

  • 4. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D, Schweinitz A, Stürzebecher A, Steinmetzer P, Schuster M, Stürzebecher U, Nicklisch S, Stürzebecher J, Steinmetzer T.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3322-9. PubMed ID: 17462889
    [Abstract] [Full Text] [Related]

  • 5. [From fibrinogen and hirudin to synthetic anticoagulants. Rational design of thrombin inhibitors].
    Steinmetzer T, Stürzebecher J.
    Pharm Unserer Zeit; 2004 Jun 15; 33(3):196-205. PubMed ID: 15208908
    [No Abstract] [Full Text] [Related]

  • 6. A personal perspective on hemostasis and thrombosis (1937-1981).
    Seegers WH.
    Semin Thromb Hemost; 1981 Dec 15; 7(3-4):177-307. PubMed ID: 7034202
    [No Abstract] [Full Text] [Related]

  • 7. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F, Lühr I, Kunze T, Mundhenke C, Maass N, Erhart T, Denker M, Beckmann D, Tiemann M, Schulte C, Dohrmann P, Cavaillé F, Godeau F, Gespach C.
    Thromb Haemost; 2007 Jun 15; 97(6):1023-30. PubMed ID: 17549306
    [Abstract] [Full Text] [Related]

  • 8. Synthetic thrombin inhibitors as anticoagulants pharmacological aspects.
    Markwardt F, Hauptmann J.
    Adv Exp Med Biol; 1993 Jun 15; 340():143-71. PubMed ID: 8154331
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitor of blood clotting derived from prothrombin.
    Marciniak E, Murano G, Seegers WH.
    Thromb Diath Haemorrh; 1967 Aug 15; 18(1-2):161-6. PubMed ID: 6071101
    [No Abstract] [Full Text] [Related]

  • 10. [Studies on the regeneration of blood clotting factors following acute plasmapheresis].
    Oishi M.
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr 15; 33(2):226-44. PubMed ID: 5530047
    [No Abstract] [Full Text] [Related]

  • 11. A thrombin inhibitor from the ixodid tick, Amblyomma hebraeum.
    Lai R, Takeuchi H, Jonczy J, Rees HH, Turner PC.
    Gene; 2004 Nov 24; 342(2):243-9. PubMed ID: 15527983
    [Abstract] [Full Text] [Related]

  • 12. Structural changes in prothrombin during activation: a theory.
    Seegers WH, Murano G, McCoy L.
    Thromb Diath Haemorrh; 1970 Feb 28; 23(1):26-36. PubMed ID: 5420433
    [No Abstract] [Full Text] [Related]

  • 13. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
    Bauer KA.
    Semin Thromb Hemost; 2002 Jun 28; 28 Suppl 2():15-24. PubMed ID: 12073176
    [Abstract] [Full Text] [Related]

  • 14. Direct thrombin inhibitors (part 1 of 2).
    Arora UK, Dhir M.
    J Invasive Cardiol; 2005 Jan 28; 17(1):34-8. PubMed ID: 15640538
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM, Firbas C, Mayr FB, Reiter RA, Steinlechner B, Jilma B.
    Clin Pharmacol Ther; 2006 Jan 28; 79(1):23-34. PubMed ID: 16413239
    [Abstract] [Full Text] [Related]

  • 16. [Experiences and modifications for the Seegers method of prothrombin preparation].
    Andrassy K, Krause W, Egbring R, Egli H.
    Thromb Diath Haemorrh; 1969 Jun 15; 21(3):561-72. PubMed ID: 5816771
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A.
    Thromb Haemost; 2002 Aug 15; 88(2):253-8. PubMed ID: 12195697
    [Abstract] [Full Text] [Related]

  • 18. Influence of platelet factor 4 on inhibited thrombin substrate reactions.
    Abildgaard U, Odegård OR, Kierulf P, Pepper DS.
    Thromb Res; 1974 Aug 15; 5(2):185-96. PubMed ID: 4472150
    [No Abstract] [Full Text] [Related]

  • 19. Study of thrombin-coagulase.
    Soulier JP, Prou-Wartelle O.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):321-34. PubMed ID: 5589292
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of "Statsep," a semiautomated device to prepare plasma samples for coagulation analysis.
    Hoppensteadt D, Walenga JM, Fareed J, Phelan K.
    Semin Thromb Hemost; 1983 Oct 31; 9(4):334-40. PubMed ID: 6658464
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.